Envestnet Portfolio Solutions’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
20,065
+707
+4% +$61.9K 0.01% 514
2026
Q1
$1.65M Buy
19,358
+4,262
+28% +$380K 0.01% 502
2025
Q4
$1.19M Buy
15,096
+72
+0.5% +$5.64K ﹤0.01% 701
2025
Q3
$1.2M Sell
15,024
-739
-5% -$63K ﹤0.01% 682
2025
Q2
$1.43M Sell
15,763
-6,466
-29% -$590K 0.01% 670
2025
Q1
$2.08M Sell
22,229
-5,014
-18% -$449K 0.01% 574
2024
Q4
$2.48M Sell
27,243
-419
-2% -$40K 0.01% 592
2024
Q3
$2.87M Buy
27,662
+874
+3% +$89.1K 0.01% 554
2024
Q2
$2.6M Buy
26,788
+2,537
+10% +$234K 0.01% 567
2024
Q1
$2.18M Buy
24,251
+5,614
+30% +$476K 0.01% 610
2023
Q4
$1.49M Buy
18,637
+2,582
+16% +$194K 0.01% 682
2023
Q3
$1.14M Buy
+16,055
New +$1.2M 0.01% 719

Other funds holding CL

Envestnet Portfolio Solutions's CL Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Colgate-Palmolive (CL) stake by 3.7% in Q2 2026, buying an estimated $61.9K and bringing the position to 20,065 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #514.

Envestnet Portfolio Solutions first reported a position in CL in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.87M in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Envestnet Portfolio Solutions held 20,065 shares of Colgate-Palmolive worth $1.84M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 707 Colgate-Palmolive shares in Q2 2026, an estimated $61.9K.
  • Colgate-Palmolive made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #514 holding.
  • Envestnet Portfolio Solutions first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Colgate-Palmolive position peaked at $2.87M in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.